142 related articles for article (PubMed ID: 35584929)
1. Glomerular Exostosin as a Subtype and Activity Marker of Class 5 Lupus Nephritis.
Wang C; Liu Y; Zhang M; Yang F; Xu F; Shi S; Zeng C; Chen X; Miao Y; Liu Z; Hu W
Clin J Am Soc Nephrol; 2022 Jul; 17(7):986-993. PubMed ID: 35584929
[TBL] [Abstract][Full Text] [Related]
2. In Patients with Membranous Lupus Nephritis, Exostosin-Positivity and Exostosin-Negativity Represent Two Different Phenotypes.
Ravindran A; Casal Moura M; Fervenza FC; Nasr SH; Alexander MP; Fidler ME; Herrera Hernandez LP; Zhang P; Grande JP; Cornell LD; Gross LA; Negron V; Jenson GE; Madden BJ; Charlesworth MC; Sethi S
J Am Soc Nephrol; 2021 Mar; 32(3):695-706. PubMed ID: 33478971
[TBL] [Abstract][Full Text] [Related]
3. Immunopathological analysis of the expression of glomerular exostosin 1 and exostosin 2 in Japanese patients with lupus nephritis.
Wada Y; Iyoda M; Suzuki T; Tachibana S; Kanazawa N; Matsumoto K; Honda H
Virchows Arch; 2021 Nov; 479(5):997-1005. PubMed ID: 34302213
[TBL] [Abstract][Full Text] [Related]
4. EXT1 and NCAM1-associated membranous lupus nephritis in a cohort of patients undergoing repeat kidney biopsies.
Miller PP; Caza T; Larsen CP; Charu V
Nephrol Dial Transplant; 2023 Feb; 38(2):396-404. PubMed ID: 35278072
[TBL] [Abstract][Full Text] [Related]
5. Rare case of exostosin 1/exostosin 2-related membranous lupus nephritis concomitant with dual ANCA- and anti-GBM antibody-associated crescentic glomerulonephritis effectively diagnosed by mass spectrometry: a case report.
Yamazaki T; Takahashi H; Takeuchi K; Sakamoto E; Tominaga K; Sakurabayashi S; Abe T; Sano T; Wada Y; Kuwahara N; Shimizu A; Takeuchi Y
BMC Nephrol; 2023 Jul; 24(1):218. PubMed ID: 37488532
[TBL] [Abstract][Full Text] [Related]
6. Exostosin-1/exostosin-2 expression and favorable kidney outcomes in lupus nephritis: a retrospective cohort study.
Zavala-Miranda MF; Sobrino-Vargas AM; Hernández-Andrade A; Caballero-Malacara V; Pérez-Arias AA; Márquez-Macedo SE; Nordmann-Gomes A; Navarro-Sánchez V; Juárez-Cuevas B; Uribe-Uribe NO; Mejia-Vilet JM
Clin Rheumatol; 2024 Jun; ():. PubMed ID: 38922553
[TBL] [Abstract][Full Text] [Related]
7. Exostosin 1/Exostosin 2-Associated Membranous Nephropathy.
Sethi S; Madden BJ; Debiec H; Charlesworth MC; Gross L; Ravindran A; Hummel AM; Specks U; Fervenza FC; Ronco P
J Am Soc Nephrol; 2019 Jun; 30(6):1123-1136. PubMed ID: 31061139
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of exostosin 1 in confirmed and suspected lupus membranous nephropathy.
Ye T; Jiang M; Zeng X; Zong D; Du Y; Li X; Huang B; Tang X
Lupus Sci Med; 2023 Dec; 10(2):. PubMed ID: 38154829
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus-related nephropathy and lupus nephritis: morphologic similarities of two clinical entities.
Lai FM; To KF; Wang AY; Choi PC; Szeto CC; Li PK; Leung CB; Lai KN
Mod Pathol; 2000 Feb; 13(2):166-72. PubMed ID: 10697274
[TBL] [Abstract][Full Text] [Related]
10. Glomerular Exostosin-Positivity is Associated With Disease Activity and Outcomes in Patients With Membranous Lupus Nephritis.
Xia X; Li S; Wang Z; Ye S; Fan Y; Peng W; Chen W; Huang F; Tang R; Chen W
Kidney Int Rep; 2024 Apr; 9(4):1040-1046. PubMed ID: 38765564
[TBL] [Abstract][Full Text] [Related]
11. Lupus-like membranous nephropathy during the postpartum period expressing glomerular antigens exostosin 1/exostosin 2 and phospholipase A2 receptor: a case report.
Miyasaka R; Wada Y; Takeuchi K; Abe T; Uchitsubo R; Kawamura S; Sakurabayashi S; Naito S; Aoyama T; Shimizu A; Takeuchi Y
CEN Case Rep; 2024 Jan; ():. PubMed ID: 38280123
[TBL] [Abstract][Full Text] [Related]
12. Glomerular Exostosin Deposits in Membranous Lupus Nephritis-a Dialogue.
Hilhorst M; Anders HJ
J Am Soc Nephrol; 2021 Mar; 32(3):525-526. PubMed ID: 33495239
[No Abstract] [Full Text] [Related]
13. The value of early renal biopsy in systemic lupus erythematosus patients presenting with renal involvement.
Hsieh YP; Wen YK; Chen ML
Clin Nephrol; 2012 Jan; 77(1):18-24. PubMed ID: 22185964
[TBL] [Abstract][Full Text] [Related]
14. [The significance of urinary podocytes in patients with active lupus nephritis].
Li JZ; Liu Y; E J; Huang HC; Yu F; Zou WZ; Wang HY
Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):127-30. PubMed ID: 17445439
[TBL] [Abstract][Full Text] [Related]
15. Treatment of exostosin 1-associated membranous lupus nephritis with multiple low doses of rituximab: A case report.
Li L; Yang Z; Tao T; Yang M; Hu ZX
Medicine (Baltimore); 2021 Mar; 100(9):e24887. PubMed ID: 33655949
[TBL] [Abstract][Full Text] [Related]
16. A Case of Pla2r and Exostosin 1 Positive Membranous Nephropathy - The Diagnostic and Therapeutic Dilemma.
Sivagnanam H; Anand M; Senthikumar PK; Velu KB; Vishwanathan R
Cureus; 2023 Aug; 15(8):e43619. PubMed ID: 37719621
[TBL] [Abstract][Full Text] [Related]
17. Renal histological findings in adults in Jamaica.
Soyibo AK; Shah D; Barton EN; Williams W; Smith R
West Indian Med J; 2009 Jun; 58(3):265-9. PubMed ID: 20043536
[TBL] [Abstract][Full Text] [Related]
18. Prolonged membranous lupus nephritis with change of anti-ssDNA antibody titer and repeated renal relapse.
Yumura W; Suganuma S; Nitta K; Sano Y; Uchida K; Nihei H
Clin Exp Nephrol; 2004 Dec; 8(4):363-8. PubMed ID: 15619038
[TBL] [Abstract][Full Text] [Related]
19. Induction therapy and outcome of proliferative lupus nephritis in the top end of Northern Australia - a single centre study retrospective study.
Xu C; Goh KL; Abeyaratne A; Priyadarshana K
BMC Nephrol; 2022 Jul; 23(1):235. PubMed ID: 35787253
[TBL] [Abstract][Full Text] [Related]
20. Lupus-like membranous nephropathy. Is it lupus? Report of 5 cases in a reference hospital in Mexico.
Ramírez-Gómez LM; Ruiz-Leija I; Martínez-Galla D; Borjas-García JA; Abud-Mendoza C;
Lupus; 2021 Jul; 30(8):1347-1357. PubMed ID: 33977794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
